Immunotherapy for the Treatment of Hymenoptera Venom Allergy in Real-life Conditions.

Launched by INMUNOTEK S.L. · Jan 17, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how safe immunotherapy (a type of treatment that helps the body get used to allergens) is for people who are allergic to insect stings, specifically from bees and wasps. The researchers want to see how well this treatment works in real-life situations, including when people accidentally get stung by these insects. The trial is taking place in multiple locations in Spain and is currently looking for participants.

To be eligible for the study, you need to be at least 14 years old and have a documented allergy to insect venom that requires treatment. Importantly, you should not have received any immunotherapy for insect venom in the last five years. Participants will be asked to sign consent forms, and if they are younger than 18, a parent or guardian must also sign. Throughout the trial, participants can expect regular follow-ups to monitor their safety and how they respond to the treatment. This study aims to provide valuable information about managing insect sting allergies effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The study population consisted of allergic participants indicated for treatment with hymenoptera venom immunotherapy (Apis mellifera or Vespula spp.) according to standard clinical practice.
• • Participants of both sexes aged 14 years or more.
• • Participants who have not received immunotherapy with hymenoptera venom in the previous 5 years.
• • Participants who have agreed to take part in the study and sign the informed consent form. In the case of minors, the patient's parent or guardian must also sign.
• Exclusion Criteria:
• • Pregnant or breastfeeding women.
• • Having received immunotherapy with hymenoptera venom during the 5 years prior to the start of the study.
• • Participants who do not agree to participate and/or do not sign the informed consent form.
• • Participants who do not comply with medical indications or do not cooperate with immunotherapy treatment.